Cite
648 Incidence and prognosis of clinically significant incidental prostate cancer in radical cystoprostatectomy for bladder cancer
MLA
E. Pérez-Fernández, et al. “648 Incidence and Prognosis of Clinically Significant Incidental Prostate Cancer in Radical Cystoprostatectomy for Bladder Cancer.” European Urology Supplements, vol. 14, Apr. 2015, p. e648. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........92289646038a13b4b20b52e136d6af10&authtype=sso&custid=ns315887.
APA
E. Pérez-Fernández, Carlos Llorente, I. Sola, I. Jiménez-Valladolid, Virginia Hernández, E. De La Peña, & A. Guijarro. (2015). 648 Incidence and prognosis of clinically significant incidental prostate cancer in radical cystoprostatectomy for bladder cancer. European Urology Supplements, 14, e648.
Chicago
E. Pérez-Fernández, Carlos Llorente, I. Sola, I. Jiménez-Valladolid, Virginia Hernández, E. De La Peña, and A. Guijarro. 2015. “648 Incidence and Prognosis of Clinically Significant Incidental Prostate Cancer in Radical Cystoprostatectomy for Bladder Cancer.” European Urology Supplements 14 (April): e648. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........92289646038a13b4b20b52e136d6af10&authtype=sso&custid=ns315887.